Concepedia

Author

Martin Larbig

Sanofi (Germany)

Also Known As

D. W. Neal, M Larbig, M. Larbig, Martin Larbig

17

Publications

408

Citations

10

H-Index

24

Concepts

All Affiliations

Sanofi (Germany)Institut für Klinische Forschung und EntwicklungJohannes Gutenberg University Mainz
ML

About

Martin Larbig is an author at Sanofi (Germany) specializing in physiology, diabetes, and electrophysiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

56

2

Health Sciences

1

1

56

3

Medicine

1

1

39

4

Natural Sciences

1

1

39

5

Applied Physiology

1

1

56

Martin Larbig

×

8

Publications

281

Citations

8

H-Index

YearCitations

Comparison between a basal‐bolus and a premixed insulin regimen in individuals with type 2 diabetes–results of the GINGER study

Andreas Fritsche, Martin Larbig, David R. Owens,

Diabetes Obesity and Metabolism

2009

101

Impact of Posture and Fixation Technique on Impedance Spectroscopy Used for Continuous and Noninvasive Glucose Monitoring

Andreas Pfützner, Andreas Caduff, Martin Larbig,

Diabetes Technology & Therapeutics

2004

56

Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.

Andreas Pfützner, Peter Herbert Kann, A Pfützner,

PubMed

2004

39

Evaluation of CGMS <sup>®</sup> During Rapid Blood Glucose Changes in Patients with Type 1 Diabetes

Birgit Wilhelm, S Först, Matthias M. Weber,

Diabetes Technology & Therapeutics

2006

27

Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial <i>β</i> ‐cell protection in individuals with type 2 diabetes

Thomas Först, Martin Larbig, C Hohberg,

Diabetes Obesity and Metabolism

2010

18

Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State

C. Hohberg, Thomas Först, Martin Larbig,

Diabetes Care

2008

17

The dipeptidyl peptidase‐4 inhibitor linagliptin lowers postprandial glucose and improves measures of <i>β</i> ‐cell function in type 2 diabetes

Tim Heise, Martin Larbig, S. Patel,

Diabetes Obesity and Metabolism

2014

12

In Type 2 Diabetes Patients, Insulin Glargine is Associated with Lower Postprandial Release of Intact Proinsulin Compared with Sulfonylurea Treatment

Stefan Pscherer, Martin Larbig, Berndt von Stritsky,

Journal of Diabetes Science and Technology

2012

11

Page 1